All-in-one Affielisa® Rat Cyclin-dependent Kinase Inhibitor 2a, Isoform 1 Elisa [ Cdkn2a] Save 80% Now [kVwqG1Xd]

AffiELISA® Rat Cyclin-dependent kinase inhibitor 2A, isoform 1 ELISA

The AffiELISA® Rat Cyclin-dependent kinase inhibitor 2A, isoform 1 ELISA [Cdkn2a] is a cutting-edge diagnostic tool designed for researchers and medical professionals seeking accurate and reliable measurements of Cyclin-dependent kinase inhibitor 2A, isoform 1 in rat samples. This highly sensitive and specific assay kit is an essential tool for understanding the role of Cdkn2a in cellular processes and disease research.

Key Product Features

The AffiELISA® Rat Cyclin-dependent kinase inhibitor 2A, isoform 1 ELISA [Cdkn2a] stands out for its exceptional performance, offering several key features that make it a preferred choice among researchers:

• High Sensitivity: Detects low levels of Cdkn2a with precision, ensuring accurate results even in complex samples.
• Specificity: Minimizes cross-reactivity with other proteins, providing reliable and accurate measurements of Cdkn2a levels.
• Easy to Use: Follows a simple, one-step procedure, making it accessible for users of all skill levels.

These features make the AffiELISA® Rat Cyclin-dependent kinase inhibitor 2A, isoform 1 ELISA [Cdkn2a] an indispensable tool for a wide range of applications in research and diagnostics.

Practical Applications

The AffiELISA® Rat Cyclin-dependent kinase inhibitor 2A, isoform 1 ELISA [Cdkn2a] is versatile and applicable in various research areas, including:

• Neoplastic Diseases: Investigating the role of Cdkn2a in tumor suppression and cancer development.
• Cellular Biology: Studying the regulation of the cell cycle and apoptosis in normal and pathological conditions.
• Developmental Biology: Examining the expression and function of Cdkn2a during embryonic development.

This comprehensive range of applications makes the AffiELISA® Rat Cyclin-dependent kinase inhibitor 2A, isoform 1 ELISA [Cdkn2a] an invaluable resource for advancing scientific knowledge and improving patient care.